The Procter Gamble Company

The Cleveland Clinic Foundation

Other

Pflow Industries, Inc.

Taigen Biotechnology Company, Ltd.

Michael Reilly

Stanley Leon Hazen

Jose Carlos Garcia-Garcia

George Franklin Gerberick

John Christian Haught

John August Wos

Yakang Lin

Steven Hamilton Hoke

Koti Tatachar Sreekrishna

Qingxin Lei

David Blair Cody

Mark R Webster

David Thomas Stanton

Angela Jane Deutsch

Ashraf Traboulsi

Xiaodong Gu

Mark Robert Sivik

Lowell Alan Sanker

Thomas Alfred Inglin

Jodie Michele Reed

Safa Motlagh

Jodie Michelle Reed

David Konopacki

Xiandong Gu

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I): 

Methods for inhibiting conversion of choline to trimethylamine (TMA)

A barrel elevator system for vertically moving barrels of liquid between a ground floor and any one of a number of floors at a warehouse for storage of the barrels. The barrel elevator system includes a support frame located in an elevator shaft and a series of cradle assemblies supported between a pair of lifting chains. A loading station is located on the ground floor for receiving barrels to be stored or for removing barrels after storage. Each floor includes a unloading station that allows barrels to be removed from the cradle for storage and returned to the cradles after storage. Each of the loading and unloading stations includes a shield assembly to restrict access to the elevator shaft. A rail section and handle are used to load and unload barrels from the cradles. The handle extends through the shield assembly for access by an operator.

Barrel elevator including shielded actuation mechanisms

The invention provides a method of inhibiting the conversion of carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): Wherein the compound is administered in an amount effective to inhibit conversion of carnitine to TMA in the individual.

Methods for inhibiting conversion of carnitine to trimethylamine (TMA)

The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline in the individual.

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I): 

A means of isolating specific stereoisomers and enantiomers from a complex mixture containing a possibility of 32 different stereoconfigurations, thus concentrating the stereoisomer or enantiomer to a high degree of purity.

Method of chromatographic separation

Personal care compositions, such as oral medication compositions containing a flavor system comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers.

Medications for deposition on biological surfaces

A moving floor system that includes a moving work surface to move work products from an upstream end to a downstream end. The moving work surface is formed from a plurality of individual carts joined to each other. The stack of carts is moved along upper support rails located at an upper level. When each individual cart reaches the downstream end, a downstream lift conveyor moves the individual cart from the upper level to a lower level. When at the lower level, each individual cart is returned from the downstream end to the upstream end. When each individual cart reaches the upstream end, an upstream lift conveyor returns the individual carts from the lower level to the upper level. An upper drive mechanism provides the motive force to move the stack of carts along the upper level at the working speed.

Moving floor system

Process for making 7-cycloamino-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acids. Borate ester compounds suitable for use in such process.

Coupling process for preparing quinolone intermediates

Growing community of inventors

Lebanon, OH, United States of America

Michael Reilly